BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9155516)

  • 41. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
    Rosser CJ; Parker A
    J Urol; 2005 Sep; 174(3):1154-5; author reply 1155-6. PubMed ID: 16094093
    [No Abstract]   [Full Text] [Related]  

  • 42. Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker.
    Hernández J; Thompson IM
    Cancer; 2004 Sep; 101(5):894-904. PubMed ID: 15329895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prostate tumor and its diagnosis].
    Yamanaka H
    Rinsho Byori; 2001 Jul; 49(7):633-7. PubMed ID: 11519121
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostate cancer: screening and treatment options.
    Horger DC; Clarke HS
    J S C Med Assoc; 2003 Apr; 99(4):85-7. PubMed ID: 12762154
    [No Abstract]   [Full Text] [Related]  

  • 45. PSA velocity and prostate cancer detection: the absence of evidence is not the evidence of absence.
    Perrin P
    Eur Urol; 2006 Mar; 49(3):418-9. PubMed ID: 16459016
    [No Abstract]   [Full Text] [Related]  

  • 46. [Prostatic specific antigen in practice in 1997].
    Salomon L; Colombel M; Patard JJ; Chopin D; Abbou CC
    Ann Urol (Paris); 1998; 32(2):69-72. PubMed ID: 9599634
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PSA: prostate-specific antigen, persisting scientific ambiguities.
    Harv Mens Health Watch; 2009 Jul; 13(12):1-6. PubMed ID: 19718841
    [No Abstract]   [Full Text] [Related]  

  • 48. Re: E. David Crawford, Per-Anders Abrahamsson. PSA-based screening for prostate cancer: how does it compare with other cancer screening tests? Eur Urol 2008;54:262-73.
    Kvåle R; Hernes E; Bray F
    Eur Urol; 2009 May; 55(5):e88-9; author reply e90-1. PubMed ID: 19062155
    [No Abstract]   [Full Text] [Related]  

  • 49. How to use PSA to screen for prostate cancer.
    Little B; Young M
    Int J Clin Pract; 2003; 57(1):40-2. PubMed ID: 12587941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prostate-specific antigen: appropriate and inappropriate use].
    Ciatto S
    Recenti Prog Med; 2003 Mar; 94(3):95-8. PubMed ID: 12677774
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Diagnosis of cancer of the prostate (I): Advancements in knowledge and practice since the consensus conference of 1989. The "Cancer of the Prostate" subcommittee of the Committee of Oncology of the French Association of Urology].
    Villers A; Grosclaude P; Haillot O; Abbou CC; Richard F; Boccon-Gibod L
    Prog Urol; 1997 Jun; 7(3):508-15. PubMed ID: 9273082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostate cancer screening is experimental.
    Cox B
    N Z Med J; 1996 Mar; 109(1017):63-4. PubMed ID: 8606819
    [No Abstract]   [Full Text] [Related]  

  • 53. [Advancements in PSA-based screening for prostate cancer].
    Ito K
    Rinsho Byori; 2004 Jul; 52(7):611-7. PubMed ID: 15344561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in the application of prostate-specific antigen in the detection of early-stage prostate cancer.
    Kamoi K; Babaian RJ
    Semin Oncol; 1999 Apr; 26(2):140-9. PubMed ID: 10597725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prostate cancer screening "reloaded".
    Gomella LG
    Can J Urol; 2010 Apr; 17(2):5057. PubMed ID: 20398441
    [No Abstract]   [Full Text] [Related]  

  • 56. Why PSA testing does have value.
    Kirby M
    Practitioner; 1997 Jul; 241(1576):363. PubMed ID: 9425708
    [No Abstract]   [Full Text] [Related]  

  • 57. [Authorities in USA don't recommend screening for prostate cancer].
    Bratt O
    Lakartidningen; 2011 Nov 16-22; 108(46):2362. PubMed ID: 22468374
    [No Abstract]   [Full Text] [Related]  

  • 58. Revisiting my personal decision about prostate-specific antigen testing in 2005.
    Barry MJ
    BJU Int; 2005 Nov; 96(7):954-6. PubMed ID: 16225507
    [No Abstract]   [Full Text] [Related]  

  • 59. European PSA testing trial update offers little guidance to American men.
    Harv Mens Health Watch; 2012 Jun; 16(11):8. PubMed ID: 22768409
    [No Abstract]   [Full Text] [Related]  

  • 60. [Prostate cancer screening using prostate specific antigen (PSA) in Tokatsu Hospital--examination of lost-to-followup cases].
    Shimizu N; Yamanaka H; Ichinose Y; Saitou Y
    Hinyokika Kiyo; 1998 Mar; 44(3):155-8. PubMed ID: 9589875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.